A And D
Pricing Report NDC 11523-1314-1

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for A And D (NDC 11523-1314-1) is $0.04859 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 18, 2014.

As a provided by Bayer Healthcare Llc., this medication is distributed in a 1 TUBE in 1 CARTON / 42.5 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.04859
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 18, 2014
Billable Units
42.5 GM
Estimated Package Price
$2.07
Data Status
As of Dec 31, 2014
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
11523-1314-1
Description
1 TUBE in 1 CARTON / 42.5 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.02958 to $0.04965 per GM. Over this 1 year and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0296 - $0.0497
Market Volatility
67.85% Variance
Latest Trend
0.59%
Date Unit Price Unit Source Method Rate
Nov 19, 2014 $0.03021 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 19, 2014 $0.03021 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Oct 22, 2014 $0.03039 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 20, 2014 $0.02958 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 20, 2014 $0.02958 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jun 18, 2014 $0.04859 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 18, 2014 $0.04859 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Jun 18, 2014 $0.04859 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
May 21, 2014 $0.04814 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 21, 2014 $0.03023 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 21, 2014 $0.03023 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 19, 2014 $0.04965 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 19, 2014 $0.04965 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Jun 20, 2013 $0.03034 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Apr 18, 2013 $0.04873 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026